The synthesized compounds were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), because these enzymes play a crucial role in the treatment of Alzheimer’s disease. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.